Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

AIM ImmunoTech Q3 EPS $(0.13) Down From $(0.08) YoY

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.13) per share. This is a 62.5 percent decrease over losses of $(0.08) per share from the same period last year.
byBenzinga Newsdesk
November 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.13) per share. This is a 62.5 percent decrease over losses of $(0.08) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Biomerica: Q3 Earnings Insights

By Benzinga Insights
April 14, 4:41 PM
Biomerica (NASDAQ:BMRA) reported its Q3 earnings results on Thursday, April 14, 2022 at 08:31 AM. Here's what investors need to know about the announcement. Earnings Biomerica beat estimated earnings by 90.0%, reporting an EPS of $-0.01 versus an estimate of $-0.1.

BMRA